The scientist’s investigation covers issues in Neuroscience, Internal medicine, Schizophrenia, Endocrinology and Psychosis. Her work deals with themes such as Brain-derived neurotrophic factor, Neurotrophin and Brain size, which intersect with Neuroscience. Her study looks at the intersection of Internal medicine and topics like Protein subunit with Receptor complex.
Her Schizophrenia study combines topics in areas such as Psychopharmacology and Clinical psychology. Her work carried out in the field of Endocrinology brings together such families of science as Receptor, Prefrontal cortex, Gene expression and White matter. Her Psychosis research is multidisciplinary, incorporating elements of Major depressive disorder, Genetics, Bipolar disorder and Reelin.
Her main research concerns Internal medicine, Schizophrenia, Endocrinology, Neuroscience and Prefrontal cortex. Her Schizophrenia study incorporates themes from Bipolar disorder, Inflammation, Psychosis and Cognition. She interconnects Major depressive disorder, Genetics and Genome-wide association study in the investigation of issues within Bipolar disorder.
Her study in Endocrinology is interdisciplinary in nature, drawing from both Receptor, Neuregulin 1, Gene expression and Gene isoform. The Neuroscience study combines topics in areas such as Schizophrenia, White matter and Psychopharmacology. Her Prefrontal cortex study integrates concerns from other disciplines, such as Messenger RNA and Human brain.
Cynthia Shannon Weickert spends much of her time researching Schizophrenia, Internal medicine, Endocrinology, Prefrontal cortex and Inflammation. Her Schizophrenia research is multidisciplinary, incorporating perspectives in Cytokine, Psychosis, Cognition, Neuroimaging and Neurogenesis. She combines subjects such as Complement inhibitor and Frontal lobe with her study of Internal medicine.
Her work in the fields of Endocrinology, such as Hippocampal formation, Hippocampus and Blood–brain barrier, overlaps with other areas such as Occludin. Her Prefrontal cortex research is multidisciplinary, relying on both Transcriptome, Glycosylation and Genomics. The subject of her Dorsolateral prefrontal cortex research is within the realm of Neuroscience.
Her primary areas of investigation include Schizophrenia, Prefrontal cortex, Inflammation, Microglia and Immune system. Her biological study spans a wide range of topics, including Cognition, Neuroimaging, Clinical psychology, Brain size and Cognitive reserve. Her Clinical psychology study combines topics from a wide range of disciplines, such as Psychosis, Neglect, Family history and Functional ability.
Cynthia Shannon Weickert has included themes like Proteome, Internal medicine, Computational biology and Endocrinology in her Prefrontal cortex study. Her Internal medicine research includes themes of Kynurenine pathway and Frontal lobe. Her Endocrinology research integrates issues from Cytokine, Kynurenic acid and Dorsolateral prefrontal cortex.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association study identifies 30 loci associated with bipolar disorder
Eli A. Stahl;Eli A. Stahl;Gerome Breen;Andreas J. Forstner;Andrew McQuillin.
Nature Genetics (2019)
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
C S Weickert;T M Hyde;B K Lipska;M M Herman.
Molecular Psychiatry (2003)
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
S G Fillman;S G Fillman;N Cloonan;V S Catts;V S Catts;L C Miller.
Molecular Psychiatry (2013)
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes
Douglas M. Ruderfer;Stephan Ripke;Stephan Ripke;Stephan Ripke;Andrew McQuillin;James Boocock.
Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease
Amanda J. Law;Barbara K. Lipska;Cynthia Shannon Weickert;Thomas M. Hyde.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
M J Green;S L Matheson;A Shepherd;C S Weickert;C S Weickert.
Molecular Psychiatry (2011)
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.
M J Webster;M B Knable;J O'Grady;J Orthmann.
Molecular Psychiatry (2002)
Widespread white matter microstructural differences in schizophrenia across 4322 individuals : results from the ENIGMA Schizophrenia DTI Working Group
S. Kelly;S. Kelly;N. Jahanshad;A. Zalesky;P. Kochunov.
Molecular Psychiatry (2018)
Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Cynthia Shannon Weickert;Richard E. Straub;Benjamin W. McClintock;Mitsuyuki Matsumoto.
Archives of General Psychiatry (2004)
Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia
Amanda J. Law;Joel E. Kleinman;Daniel R. Weinberger;Cynthia Shannon Weickert.
Human Molecular Genetics (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: